CHRONIC PULMONARY LPS TOLERANCE INDUCES SELECTIVE IMMUNOSUPPRESSION WHILE MAINTAINING THE NEUTROPHILIC RESPONSE
- 1 February 2010
- journal article
- basic science-aspects
- Published by Wolters Kluwer Health in Shock
- Vol. 33 (2) , 162-169
Abstract
LPS challenge causes potent activation of innate immunity. Because LPS is ubiquitously present in ambient air, repeated inhalation may lead to activation of the pulmonary immune response. If this activation is unregulated, chronic LPS inhalation would lead to persistent inflammation and organ damage. We hypothesized that the lung uses the mechanism of LPS tolerance to maintain the balance between hypoinflammatory and hyperinflammatory states. We developed a model of chronic pulmonary LPS tolerance induced by pulmonary exposure to 1 μg LPS for 4 consecutive days. Mice were challenged with 10 μg of LPS 24 h later. TNF-α protein was significantly decreased in the bronchoalveolar lavage fluid of tolerant versus nontolerant mice, whereas IL-6 levels were significantly increased in the tolerant group. Tolerant mice were also protected from airway hyperresponsiveness. M2 and M3 muscarinic receptor mRNA was significantly decreased in the lungs of tolerant mice, suggesting a mechanism for the decreased airway hyperresponsiveness. CXCL2 was significantly reduced in tolerant mice, but CXCL1 was equivalent between groups. No difference was seen in neutrophil recruitment to the alveolar space. Interestingly, LPS tolerance does not confer cross-tolerance to the Toll-like receptor (TLR) 2 stimulus Pam3Cys. TNF-α and IL-6 concentrations were significantly increased in LPS-tolerant mice challenged with Pam3Cys; however, chemokine concentrations were unaffected. Our data show that repeated LPS inhalation results in differential regulation of cytokines but does not inhibit neutrophil recruitment. This unrestricted neutrophil recruitment may represent a mechanism by which individuals may be protected from pulmonary bacterial infection and pneumonia.Keywords
This publication has 42 references indexed in Scilit:
- THE SYSTEMIC AND PULMONARY LPS BINDING PROTEIN RESPONSE TO INTRATRACHEAL LIPOPOLYSACCHARIDEShock, 2009
- Infection with Human Metapneumovirus Predisposes Mice to Severe Pneumococcal PneumoniaJournal of Virology, 2009
- INDUCTION OF ENDOTOXIN TOLERANCE ENHANCES BACTERIAL CLEARANCE AND SURVIVAL IN MURINE POLYMICROBIAL SEPSISShock, 2008
- Dynamics of pro-inflammatory and anti-inflammatory cytokine release during acute inflammation in chronic obstructive pulmonary disease: an ex vivo studyRespiratory Research, 2008
- TNFα blockade in human diseases: Mechanisms and future directionsClinical Immunology, 2008
- Spontaneous Airway Hyperresponsiveness in Estrogen Receptor-α–deficient MiceAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Oxygenation Inhibits the Physiological Tissue-Protecting Mechanism and Thereby Exacerbates Acute Inflammatory Lung InjuryPLOS Biology, 2005
- Reduced cancer rates in agricultural workers: a benefit of environmental and occupational endotoxin exposureMedical Hypotheses, 2000
- IMPAIRED EX VIVO LIPOPOLYSACCHARIDE-STIMULATED WHOLE BLOOD TUMOR NECROSIS FACTOR PRODUCTION MAY IDENTIFY “SEPTIC” INTENSIVE CARE UNIT PATIENTSShock, 2000
- Lipopolysaccharide (LPS) recognition in macrophages. Participation of LPS-binding protein and CD14 in LPS-induced adaptation in rabbit peritoneal exudate macrophages.Journal of Clinical Investigation, 1993